Fennec Pharmaceuticals Inc. (FENC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Fennec Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$10.87
+2.35% today
Market cap
$372M
Overall quality
70/100
Kronos AI 30-day
+2.0%
5 of 8 simulated paths end higher
Fennec Pharmaceuticals Inc. (FENC) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $372M. It trades at $10.87, up 2.35% today. Its overall quality score is 70 out of 100, ranked against the whole US market. 3 analysts' average target of $17.60 implies +61.9% from today's price. Kronos AI's 30-day forecast is +2.0% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $17.60 |
| Low – high | $16.00 – $20.00 |
| Analysts | 3 |
| Upside to average | +61.9% |
Kronos AI 30-day forecast
| Expected close | $10.83 (+2.0%) |
| Likely range | −12.8% … +15.1% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
| Profitability | 37 |
| Solvency | 85 |
| Growth | 87 |
| Overall | 70 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.